Clinical and prognostic profile of Her2neu positive (non-luminal) intrinsic breast cancer subtype: comparison with Her2neu positive luminal breast cancers [PDF]
BMC Research Notes, 2018 Objective Her2neu receptor is proto-oncogene which can be over-expressed in both luminal and non-luminal breast cancers. In the present study, we aimed to compare the prognostic and predictive factors like tumor grade, T-stage, N-stage and ki67 index in ...
Atif Ali Hashmi +2 more
exaly +5 more sources
Breast cancer imaging features as a predictor of the hormonal receptor status, HER2neu expression and molecular subtype [PDF]
Egyptian Journal of Radiology and Nuclear Medicine, 2020 Background Determination of the hormonal receptor (HR) status, HER2neu expression, and the molecular subtype has valuable diagnostic, therapeutic, and prognostic implications for breast cancer as breast cancer stratification during the last two decades ...
Maged Abdelfattah Ali Algazzar +3 more
exaly +4 more sources
Evaluation of HER2Neu Status in Periampullary Cancers in Tertiary Care Centre in Northern India: A Three-Year Retrospective Study [PDF]
Cureus, 2023 Background Periampullary carcinoma is a heterogeneous group of malignancies, and despite advances in treatment, its mortality rate remains high. A better understanding of the disease and factors influencing its course and potential therapeutic targets is imperative for improving its overall outcome.
Akshay Anand, Sameer Gupta
exaly +4 more sources
Role of HER2neu expression in gastric cancer
Indian Journal of Pathology and Microbiology, 2021 Background: Gastric cancer is one of the most common cancers in the world and is responsible for over a million deaths. Gastric cancer broadly consists of two main histological types, diffuse and intestinal, and can be further classified as proximal ...
J S Sukanya +2 more
doaj +3 more sources
Clinicopathological Significance and Prognostic Role of Her2neu Protein Expression in Patients with Carcinoma Stomach: A Prospective Study from Northern India [PDF]
South Asian Journal of Cancer, 2023 Shashikant C U Patne, Vinod Kumar Dixit
exaly +4 more sources
Societal Costs and Benefits of Treatment with Trastuzumab in Patients with Early HER2neu-Overexpressing Breast Cancer in Singapore [PDF]
BMC Cancer, 2011 Background Trastuzumab has revolutionized the way we treat early Her2Neu-positive breast cancer, as it significantly improves disease-free and overall survival.
Gilberto de Lima Lopes
core +5 more sources
Biomedical and Biotechnology Research Journal, 2022 Background: Gastric carcinomas are the fifth most common cancer worldwide and cause the second most common cancer-related deaths. Human epidermal growth factor receptor 2 (HER-2/Neu)(c-erbB2) protein overexpression in gastric cancer has been correlated ...
Dipsikha Chakraborty +4 more
exaly +3 more sources
Trichorhinophalangeal syndrome type 1 (TRPS1) in breast pathology: diagnostic utility and pitfalls [PDF]
Diagnostic PathologyIntroduction Breast cancer, especially triple-negative breast cancer (TNBC), lacks sensitive and specific diagnostic markers that can reliably differentiate it from carcinomas of other origins.
Atif Ali Hashmi +2 more
doaj +2 more sources
Targeted therapies in primary vaginal cancer [PDF]
Journal of Cancer Research and Clinical OncologyObjective Primary vaginal cancer (PVC) accounts for 1–2% of all gynecological malignancies. Therefore, clinical trials lack and there is a paucity of approved medications beyond radiation or chemoradiation as main first line therapy.
Laura Tascón Padrón +7 more
doaj +2 more sources
Interpretation of ER and Her2neu hormonal receptor in breast cancer [PDF]
Medical Journal Armed Forces India, 2016 Tanushri Mukherjee
exaly +3 more sources